A new Covid vaccine and Molnupravir, an oral medicine for treating the disease, could be available in Poland in December, a senior medical official said on Tuesday.
Covid-19 vaccine production may start on an industrial scale at Polish biotech firm Mabion in the third quarter of this year, the head of the Polish Development Fund told the Money.pl portal on Wednesday.
Talks aimed at establishing Covid-19 vaccine production capabilities in Poland are ongoing between Polish authorities and companies, a pharmaceutical official has said.
Poland's plans to contain the coronavirus pandemic this year are viable, the CEO of the Polish branch of the US pharmaceutical company Pfizer has told PAP.
In this episode of The Debrief, we get the inside info from Mabion, a Polish biotech firm which has teamed up with Novavax in the US to produce Covid vaccines.
Biotech firm Mabion said it had signed a deal with the US company for the ‘transfer of technology and technological trials in the manufacture of an antigen for Novavax's Covid-19 vaccine’.